openPR Logo
Press release

Indian In Vitro Diagnostics Market Sales Revenue Opportunity Report 2018

07-04-2017 07:55 AM CET | Health & Medicine

Press release from: Kuick Resarch

Indian In Vitro Diagnostics Market Sales Revenue Opportunity

The Indian IVD market is valued at more than US$ 500 Million, and is expected to surpass US$ 1.5 Billion by 2018 growing steady at a CAGR of 20%. This remarkable growth can be attributed to increased healthcare awareness, desire to undergo preventive health checkups, availability of disease specific tests, corporate setups promoting health focus of employees, and drift from manual to semi-automated and automated equipment. Emergence of new concepts like point of care testing, near patient testing, increased automation, hospital laboratory management and customer relationship management have revolutionized this segment and contributed towards providing accurate and precise diagnosis at much faster rates.

Download Report:

https://www.kuickresearch.com/report-Indian-In-Vitro-Diagnostics-Market-Analysis-2018.php

For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990

"Indian In Vitro Diagnostics Market Analysis 2018" Table of Contents

1. India IVD Market Outlook
1.1 Market Introduction
1.2 Current Market Scenario

2. India IVD Market Dynamics
2.1 Market Growth Drivers
2.2 Market Restraints

3. IVD Market by Device & Reagents
3.1 Immunochemistry
3.2 Biochemistry
3.3 Hematology
3.4 Blood Gas & Electrolyte
3.5 Molecular Diagnostics
3.6 Urinalysis
3.7 Coagulation Analysis
3.8 Microbiology

4. Emerging Market Trends
4.1 Rising Lab Automation
4.2 Transition towards Preventive Health Checkups
4.3 Entry of Corporate Chains

5. India IVD Market Future Outlook

6. Regulation & Policy Framework
6.1 Registration of Imported IVD Reagents & Devices
6.2 Registration/ Re-Registration of Notified Medical Devices
6.3 Conducting Clinical Trials of Medical Devices
6.4 Import of Non-Notified Diagnostic Kits
6.5 Import of Notified Diagnostics Kits

7. Competitive Landscape
7.1 Abbott Diagnostic
7.2 Agappe Diagnostics
7.3 Accurex Biomedical
7.4 Transasia Bio-Medicals
7.5 Roche Diagnostics

Figure 1-1: In Vitro Diagnostic Market (US$ Million), 2012-2018
Figure 1-2: In Vitro Diagnostic Reagents Market (US$ Million), 2012-2018
Figure 1-3: In Vitro Diagnostic Instruments Market (US$ Million), 2012-2018
Figure 1-4: In Vitro Diagnostic Market by Reagent & Instrument (%), 2013 & 2018
Figure 1-5: In Vitro Diagnostic Market by Segment (%), 2013 & 2018

Figure 3-1: Immunochemistry Market (US$ Million), 2012-2018
Figure 3-2: Immunochemistry Instruments Market (US$ Million), 2012-2018
Figure 3-3: Immunochemistry Reagents Market (US$ Million), 2012-2018
Figure 3-4: Immunochemistry Reagents Market by Segment (%), 2013 & 2018

Figure 3-5: Biochemistry Market (US$ Million), 2012-2018
Figure 3-6: Biochemistry Reagents Market (US$ Million), 2012-2018
Figure 3-7: Biochemistry Instruments Market (US$ Million), 2012-2018
Figure 3-8: Biochemistry Instrument Market by Segment (%), 2013 & 2018

Figure 3-9: Hematology Market (US$ Million), 2012-2018
Figure 3-10: Hematology Reagents Market (US$ Million), 2012-2018
Figure 3-11: Hematology Instruments Market (US$ Million), 2012-2018
Figure 3-12: Hematology Instrument Market by Segment (%), 2013 & 2018
Figure 3-13: Blood Gas & Electrolyte Market (US$ Million), 2012-2018
Figure 3-14: Blood Gas & Electrolyte Reagents Market (US$ Million), 2012-2018
Figure 3-15: Blood Gas & Electrolyte Analyzers Market (US$ Million), 2012-2018

Figure 3-16: Molecular Diagnostic Market (US$ Million), 2012-2018
Figure 3-17: Molecular Diagnostic Reagents Market (US$ Million), 2012-2018
Figure 3-18: Molecular Diagnostic Instruments Market (US$ Million), 2012-2018
Figure 3-19: Molecular Diagnostic Reagent Market by Segment (%), 2013 & 2018

Figure 3-20: Urinalysis Market (US$ Million), 2012-2018
Figure 3-21: Urinalysis Reagents Market (US$ Million), 2012-2018
Figure 3-22: Urinalysis Instruments Market (US$ Million), 2012-2018
Figure 3-23: Urinalysis Instruments Market by Segment (%), 2013 & 2018

Figure 3-24: Coagulation Market (US$ Million), 2012-2018
Figure 3-25: Coagulation Reagents Market (US$ Million), 2012-2018
Figure 3-26: Coagulation Instruments Market (US$ Million), 2012-2018

Figure 3-27: Microbiology Market (US$ Million), 2012-2018
Figure 3-28: Microbiology Reagents Market (US$ Million), 2012-2018
Figure 3-29: Microbiology Instruments Market (US$ Million), 2012-2018

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
Avanta Business Center 4th Floor,
Statesman House Barakhamba Road,
Connaught Place New Delhi – 110 001, India
+91-11-47067990

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Indian In Vitro Diagnostics Market Sales Revenue Opportunity Report 2018 here

News-ID: 606909 • Views:

More Releases from Kuick Resarch

Lumakras Drug Clinical Insight and Sales Forecast 2026
Lumakras Drug Clinical Insight and Sales Forecast 2026
"Lumakras Drug Clinical Insight and Sales Forecast 2026" Report Highlights: * NSCLC Targeting Lumakras Market Opportunity (US$ Million) * Colorectal Cancer Targeting Lumakras Market Opportunity (US$ Million) * Pharmacokinetics of Lumakras (Sotorasib) * Dosage, Patent and Price Analysis * Lumakras Ongoing Clinical Trials * Global KRAS Protein Inhibitors Clinical Trials Download Report: https://www.kuickresearch.com/report-lumakras-sotorasib-sales-forecast-fda-approved-kras-inhibitor-clinical-trials-non-small-cell-lung-cancer-nslc-g12c-mutation-c30h30f2n6o3-ras-gtpase The rising burden of cancer and the increasing cancer mortality rates possesses an unmet need for the development of novel therapies in the management
Global EZH2 Inhibitor Market Opportunity, Sales and Clinical Trials Insight 2026
Global EZH2 Inhibitor Market Opportunity, Sales and Clinical Trials Insight 2026
"Global EZH2 Inhibitor Market Opportunity, Sales and Clinical Trials Insight 2026" Report Highlights: * Global EZH2 Inhibitor Market Opportunity > US$ 1.2 Billion by 2026 * Tazverik (Tazemetostat) First Approved EZH2 Inhibitor Drug * Dosage, Price and Sales Analysis of Tazverik * Tazverik Sales Opportunity > US$ 900 Million by 2026 * Tazverik Sales Forecast 2021 Till 2026 * EZH2 Inhibitor Clinical Pipeline Overview By Company, Indication and Phase * EZH2 Inhibitor in Clinical Trials: 7 Drugs Download
Global Bispecific Antibody Market Opportunity, Drug Sales, Price and Clinical Trials Insight 2028
Global Bispecific Antibody Market Opportunity, Drug Sales, Price and Clinical Tr …
"Global Bispecific Antibody Market Opportunity, Drug Sales, Price and Clinical Trials Insight 2028" Report Highlights: * Global Bispecific Antibody Market Opportunity: > US$ 20 Billion * Global Bispecific Antibody Market Growth Rate: 100% CAGR (2016 -2021) * Approved Bispecific Antibodies In Market: 4 Antibodies * Detailed Market Sales and Trends Insight Till 2028 * Quarterly and Yearly Sales Insight Of Approved Antibodies Till Q1 2022 * Global and Regional Market Analysis * Approved Drug Sales
Global Fibroblast Growth Factor Receptor Inhibitor Drug Market Opportunity and Clinical Trials Insight 2026
Global Fibroblast Growth Factor Receptor Inhibitor Drug Market Opportunity and C …
"Global Fibroblast Growth Factor Receptor Inhibitor Drug Market Opportunity and Clinical Trials Insight 2026" Report Highlights: * Global FGFR Inhibitors Market Opportunity: > USD 4 Billion by 2026 * Role of FGFR Inhibitors in Cancer Therapy * Global FGFR Market Assessment (US$) by Region and Cancer Type Clinical and Sales Insight on Approved FGFR Inhibitors: 3 (Belvesra, Pemazyre and Truseltiq) * Dosage and Drug Price Insight on Approved FGFR Inhibitors * Comprehensive Clinical Trials Insight

All 5 Releases


More Releases for Figure

Floralite - Reduce Fat & Get Attractive Figure How To Buy!
Floralite Have you been working on your eating routine without seeing the results that you are anticipating? There is indeed thing called Floralite diet pills. Advantages of Floralite Floralite One of various things to esteem about this thing is that it's made expressly for the Floralite diet. That is an epic notwithstanding considering the way that when you use a thing that is custom fitted to work with the movements
THE WORLD'S MOST CONTROVERSIAL ACTION FIGURE...EVER!
FOR IMMEDIATE RELEASE THE WORLD'S MOST CONTROVERSIAL ACTION FIGURE...EVER! Contact: William Hirsch - Schlock Toys @ +1-949-677-9353 or DocSchlock@SchlockToys.com Featured on Tomi with Fox News host Tomi Lahren! SCHLOCK TOYS join forces with Kickstarter to Make Toys Great Again! The Kickstarter campaign page can be found HERE: https://www.kickstarter.com/projects/schlocktoys/collectors-edition-talking-trump-2020-man-of-action-figure/description “What a great message to be sent, and I think Trump himself would love this and that he’d be excited about it!” - Tomi Lahren, Fox News “You
Macarons Market Latest Sales Figure Signals More Opportunities Ahead
Global Macarons Sales Market(Sales,Revenue and competitors Analysis of Major Market)from 2014-2026 is latest research study released by HTF MI evaluating the market, highlighting opportunities, risk side analysis, and leveraged with strategic and tactical decision-making support. The study provides information on market trends and development, drivers, capacities, technologies, and on the changing investment structure of the Global Macarons Market. Some of the key players profiled in the study are La Dure,
Global Womens Figure Skates Market Growth 2019-2024
LP INFORMATION offers a latest published report on Womens Figure Skates Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. According to this study, over the next five years the Womens Figure Skates market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019.
Figure Skating Equipment Market Report 2018: Segmentation by Type (Figure Skate …
Global Figure Skating Equipment market research report provides company profile for SP-Teri, Graf Skate, Riedell Shoes, Roces, American Athletic, Rollerblade, Winnwell, Dongguan King Line, Jackson Ultima, HD Sports(MK Blades, John Wilson), Edea, Risport Skates, Paramount Skates and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY
Long-lasting Performance Improvement with Key Figure Analysis
Vienna/Reutlingen, October 17, 2012 – Manz, a leading high-tech mechanical engineering company, is optimizing its processes in strategic sourcing in order to recognize the risks and potential associated with each supplier early on so that the sourcing department can react to them in time. POOL4TOOL’s customized eSolutions localize and analyze key figures that are relevant to the decision making process, and displays these figures in a comprehensive and transparent way.